Total Payments
$9,242
2024 Payments
$2,804
Companies
34
Transactions
231
Medicare Patients
5,510
Medicare Billing
$435,739
Payment Breakdown by Category
Food & Beverage$6,585 (71.2%)
Travel$2,541 (27.5%)
Education$71.01 (0.8%)
Consulting$45.00 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,585 | 214 | 71.2% |
| Travel and Lodging | $2,541 | 12 | 27.5% |
| Education | $71.01 | 4 | 0.8% |
| Consulting Fee | $45.00 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,131 | 23 | $0 (2024) |
| BIOTRONIK INC. | $2,105 | 12 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $605.20 | 37 | $0 (2024) |
| Abbott Laboratories | $585.41 | 11 | $0 (2024) |
| PFIZER INC. | $539.09 | 24 | $0 (2024) |
| Amgen Inc. | $427.98 | 12 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $403.54 | 15 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $340.89 | 10 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $328.23 | 21 | $0 (2024) |
| ABIOMED | $312.10 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,804 | 103 | Boston Scientific Corporation ($705.02) |
| 2023 | $723.23 | 34 | E.R. Squibb & Sons, L.L.C. ($141.93) |
| 2022 | $561.70 | 26 | PFIZER INC. ($156.68) |
| 2021 | $213.38 | 12 | Amgen Inc. ($76.02) |
| 2020 | $104.20 | 3 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($77.03) |
| 2019 | $950.47 | 21 | Abbott Laboratories ($280.88) |
| 2018 | $1,748 | 18 | BOSTON SCIENTIFIC CORPORATION ($1,209) |
| 2017 | $2,137 | 14 | BIOTRONIK INC. ($2,105) |
All Payment Transactions
231 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $27.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/16/2024 | Vital Connect, Inc | VITALPATCH RTM (Device) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: CARDIOLOGY | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $28.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $9.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Genetic Disease | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $4.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/20/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/18/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $0.94 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/04/2024 | AGEPHA Pharma FZ LLC | LODOCO (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Cardiovascular Diseases | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/21/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.06 | General |
| Category: Cardiovascular | ||||||
| 10/18/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $8.18 | General |
| Category: Cardiovascular | ||||||
| 10/18/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $7.74 | General |
| Category: Cardiovascular | ||||||
| 10/17/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/15/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $36.00 | General |
| Category: Structural Heart | ||||||
| 10/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $6.66 | General |
| Category: Cardiovascular | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/04/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $7.02 | General |
| Category: Cardiovascular | ||||||
| 10/03/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $14.60 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/25/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Not Applicable | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,517 | 2,035 | $379,954 | $115,612 |
| 2022 | 24 | 1,603 | 2,307 | $411,640 | $115,667 |
| 2021 | 17 | 1,039 | 1,202 | $212,814 | $79,534 |
| 2020 | 18 | 1,351 | 1,550 | $316,260 | $124,926 |
Total Patients
5,510
Total Services
7,094
Medicare Billing
$435,739
Procedure Codes
90
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 71 | 163 | $28,460 | $15,113 | 53.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 107 | 107 | $64,499 | $14,886 | 23.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 167 | $26,685 | $12,983 | 48.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 89 | 92 | $28,310 | $12,293 | 43.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 38 | 38 | $40,900 | $11,963 | 29.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 74 | 74 | $19,240 | $9,043 | 47.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 58 | 58 | $28,680 | $7,392 | 25.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 130 | 130 | $29,300 | $6,313 | 21.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 25 | 100 | $10,656 | $4,171 | 39.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 406 | 605 | $29,970 | $3,738 | 12.5% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 21 | 42 | $9,450 | $3,663 | 38.8% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 17 | 33 | $4,950 | $2,961 | 59.8% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 17 | 18 | $7,580 | $2,376 | 31.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 42 | 42 | $11,928 | $2,006 | 16.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 136 | 182 | $11,297 | $1,865 | 16.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 25 | $2,745 | $1,726 | 62.9% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 19 | 19 | $4,085 | $1,034 | 25.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 12 | 12 | $8,555 | $602.94 | 7.0% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 20 | 20 | $3,045 | $309.24 | 10.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 23 | 29 | $435.00 | $237.10 | 54.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 14 | 18 | $1,260 | $236.16 | 18.7% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 12 | 12 | $1,123 | $179.35 | 16.0% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Office | 2023 | 11 | 11 | $4,125 | $173.81 | 4.2% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 13 | 14 | $620.00 | $137.62 | 22.2% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 12 | 12 | $1,576 | $118.89 | 7.5% |
About Dr. Ryan Chizner, DO
Dr. Ryan Chizner, DO is a Cardiovascular Disease healthcare provider based in Cartersville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2012. The National Provider Identifier (NPI) number assigned to this provider is 1548529662.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Chizner, DO has received a total of $9,242 in payments from pharmaceutical and medical device companies, with $2,804 received in 2024. These payments were reported across 231 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($6,585).
As a Medicare-enrolled provider, Chizner has provided services to 5,510 Medicare beneficiaries, totaling 7,094 services with total Medicare billing of $435,739. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Cartersville, GA
- Active Since 05/09/2012
- Last Updated 08/02/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1548529662
Products in Payments
- JETSTREAM (Device) $910.28
- WATCHMAN Access System (Device) $678.19
- ELIQUIS (Drug) $458.92
- Repatha (Biological) $410.72
- VYNDAQEL (Drug) $393.00
- LifeVest (Device) $340.89
- Impella (Device) $312.10
- CAMZYOS (Drug) $292.37
- BRILINTA (Drug) $264.10
- LEQVIO (Drug) $230.55
- AMPLATZER AMULET (Device) $194.60
- VERQUVO (Drug) $185.01
- XARELTO (Drug) $174.91
- CROSSBOSS (Device) $138.11
- Vascepa (Drug) $128.17
- FARXIGA (Drug) $121.45
- Optis Coronary Imaging System (Device) $121.43
- GENERAL VASCULAR ACCESS (Device) $113.21
- GENERAL VASCULAR ACCESS (Device) $102.83
- ENTRESTO (Drug) $97.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Cartersville
Maxwell Prempeh, Md, MD
Cardiovascular Disease — Payments: $65,029
Cardiovascular Disease $65,029
Digant Bhatt, Md, MD
Cardiovascular Disease — Payments: $9,793
Cardiovascular Disease $9,793
Rajeeve Subbiah, Md, MD
Cardiovascular Disease — Payments: $5,304
Cardiovascular Disease $5,304
Dr. Suresh Ramamurthy, Md, MD
Cardiovascular Disease — Payments: $5,248
Cardiovascular Disease $5,248
Godly Jack, Md, MD
Cardiovascular Disease — Payments: $2,439
Cardiovascular Disease $2,439
Ravinder Reddy, M.d, M.D
Cardiovascular Disease — Payments: $83.04
Cardiovascular Disease $83.04